Novel anti-CD19 plus lenalidomide prolonged survival in R/R DLBCL ExpertDr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA TrialCohort study, RE-MIND2 ConferenceASH 2021 4 February, 2022 11:08